Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular, Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular and Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, coughs and colds, and attention deficit/hyperactivity disorder (ADHD).
Founded in 1992 and headquartered in Atlanta, Georgia, Sciele Pharma employs more than 1,000 people. The Company's success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform - an Entrepreneurial Spirit, Innovation, Execution Excellence, Simplicity, and Teamwork.
Contact informationMedical inquiries or concerns should be directed to the Sciele Pharma, Inc. Medical Information and Drug Safety Department:
For more information about Sciele Pharma, Inc.
visit us at www.sciele.com.
Metafolin® is a registered trademark
of Merck KGaA, Germany.
The images contained herein are
trademarks of Sciele Pharma, Inc.
PRE-WEB-01
©2008 Sciele Pharma, Inc.
Privacy Policy/Legal Terms of Use